Genetic analysis of chromosome 22q11.2 Markers in congenital heart disease

Journal of Clinical Laboratory Analysis

Volumn 17, Issue 1, 2003, Pages 28-35

  Shi, Yi Ru ^a   Hsieh, Kai Sheng ^b   Wu, Jer Yuarn ^a   Lee, Cheng Chun ^a   Tsai, Chang Hai ^a   Yu, Ming Tseng ^a   Chang, Jeng Sheng ^a   Tsai, Fuu Jen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Veterans General Hospital   (Taiwan)

Author keywords

CHD; Chromosome 22q11.2; Microdeletion; STRP marker

Indexed keywords

ARTICLE; CHROMOSOME 22Q; CONGENITAL HEART DISEASE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC MARKER; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; TANDEM REPEAT;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; DNA; GENE DELETION; GENETIC MARKERS; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MINISATELLITE REPEATS; POLYMERASE CHAIN REACTION;

EID: 12244269087     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10062     Document Type: Article

References (13)

1. Hoffman JI. Incidence of congenital heart disease. II. Prenatal incidence. Pediatr Cardiol 1995;16:155-165.
2. Bristow J. The search for genetic mechanisms of congenital heart disease. Cell Mol Biol Res 1995;41:307-319.
3. Payne RM, Johnson MC, Grant JW, Strauss AW. Toward a molecular understanding of congenital heart disease. Circulation 1995;91:494-504.
4. Amati F, Mari A, Digilio MC, et al. 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet 1995;95:479-482.
5. Mehraein Y, Wippermann CF, Michel-Behnke I, et al. Microdeletion 22q11 in complex cardiovascular malformations. Hum Genet 1997;99:433-442.
6. Van Mierop LH, Kutsche LM. Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor. Am J Cardiol 1986;58:133-137.
7. Young D, Shprintzen RJ, Goldberg RB. Cardiac malformations in the velocardiofacial syndrome. Am J Cardiol 1980;46:643-648.
8. Matsuoka R, Takao A, Kimura M, et al. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am J Med Genet 1994;53:285-289.
9. Discoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velo-cardio-facial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993;30:813-817.
10. Carlson C, Sirotkin H, Pandita R, et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet 1997;61:620-629.
11. Morrow B, Goldberg R, Carlson C, et al. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet 1995;56:1391-1403.
12. Momma K, Kondo C, Matsuoka R, Takao A. Cardiac anomalies associated with a chromosome 22q11 deletion in patients with conotruncal anomaly face syndrome. Am J Cardiol 1996;78:591-594.
13. Shi YR, Hsieh KS, Wu JY, Lee CC, Tsai CH, Tsai FJ. Molecular analysis of syndromic congenital heart disease using short tandem repeat markers and semiquantitative polymerase chain reaction method. Pediatr Int 2002;44:264-268.